Release Date: 20/07/10 16:41 Summary: Capital Raising Announcement Price Sensitive: Yes Download Document 163.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%